U.S. flag

An official website of the United States government

NM_000104.4(CYP1B1):c.350G>T (p.Arg117Leu) AND Congenital glaucoma

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jul 16, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003031051.3

Allele description [Variation Report for NM_000104.4(CYP1B1):c.350G>T (p.Arg117Leu)]

NM_000104.4(CYP1B1):c.350G>T (p.Arg117Leu)

Gene:
CYP1B1:cytochrome P450 family 1 subfamily B member 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p22.2
Genomic location:
Preferred name:
NM_000104.4(CYP1B1):c.350G>T (p.Arg117Leu)
HGVS:
  • NC_000002.12:g.38075039C>A
  • NG_008386.2:g.6063G>T
  • NM_000104.4:c.350G>TMANE SELECT
  • NP_000095.2:p.Arg117Leu
  • NC_000002.11:g.38302182C>A
Protein change:
R117L
Molecular consequence:
  • NM_000104.4:c.350G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Congenital glaucoma
Identifiers:
MONDO: MONDO:0020366; MedGen: C0020302

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003314176Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jul 16, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mutational screening of CYP1B1 in Turkish PCG families and functional analyses of newly detected mutations.

Bagiyeva S, Marfany G, Gonzalez-Angulo O, Gonzalez-Duarte R.

Mol Vis. 2007 Aug 27;13:1458-68.

PubMed [citation]
PMID:
17893647

Functional and Structural Analyses of CYP1B1 Variants Linked to Congenital and Adult-Onset Glaucoma to Investigate the Molecular Basis of These Diseases.

Banerjee A, Chakraborty S, Chakraborty A, Chakrabarti S, Ray K.

PLoS One. 2016;11(5):e0156252. doi: 10.1371/journal.pone.0156252.

PubMed [citation]
PMID:
27243976
PMCID:
PMC4887111
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003314176.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 117 of the CYP1B1 protein (p.Arg117Leu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with congenital glaucoma (Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 2098650). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on CYP1B1 protein function. This variant disrupts the p.Arg117 amino acid residue in CYP1B1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17893647, 27243976). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024